Jiangxi Zhengbang Technology Co., Ltd.

Money comes from one-time product sales rather than recurring fees, dominated by the sale of live pigs and piglets, with manufactured feed as a large secondary source and veterinary products a marginal one. Sales flow both directly to buyers and through distributors, and a substantial share of revenue comes from transactions with the group that controls the company.

The company describes its own scaling as limited by the capital needed to build new farms, a constraint it says its farmer-partnership model relieves by adding outside land, facilities and labour rather than funding all construction itself. Its filings also say capacity already built has been running under-used, with depreciation on idle facilities adding to production cost, so recent scale has not translated into full use of existing capacity.

Its own filings describe deep dependence on the group that controls it: that group's affiliates supply live pigs, breeding semen, raw materials, packaging, feed, veterinary drugs, logistics, equipment and even construction work, and its feed and veterinary-drug operations run on that same group's shared management platform. It also depends on leased rural land for its farming sites and on independent farmer partners who contribute the facilities and labour behind much of its fattening capacity.

A wide base of downstream buyers depends on it for animal protein inputs: township feed distributors, independent and scaled pig farms, wholesalers, meat processors and veterinary-drug agents all buy from it. Its own disclosures show this base is unusually concentrated at the top, with a single customer, one its filings tie to the same group that controls the company, accounting for a large share of annual sales.

CompanyGraph's mapping shows a very large number of companies run the same basic kind of feed-to-livestock production system, so this underlying conversion process is a common structure, not a scarce one. The company's own filings name breeding stock, biosecurity controls, digital management and ties to its controlling shareholder as strengths, and identify no external competitor by name, only its own controlling shareholder's group, whose business it says partially overlaps with its own.

The broader pattern CompanyGraph tests against companies that convert purchased inputs into livestock at a fixed physical rate is a capacity ceiling set by farm and feed-plant throughput. Tested against this company specifically, its own account points less to a hard throughput ceiling and more to the capital needed to build new farms, a bottleneck it says its farmer-partnership model relieves, and it separately states that capacity already built has been running under-used, adding idle-asset costs to production.

Its own disclosures show a meaningful share of revenue concentrated in one customer that sits inside the same group that controls the company, and the risks it names first, in its own words, are biological and physical, disease among its animals, food safety failures and natural disasters, ahead of price or competitive risk. Separately, CompanyGraph's recomputation of its financial statements shows net income has been negative in some recent fiscal years, including one very large loss, alongside a large amount of pending litigation the company discloses on both sides of the docket.

The company's own risk disclosures put biological and physical threats first, naming disease among its livestock, food safety and natural disasters ahead of price swings, its own operating model or competition. It also operates under rules set by securities regulators and agricultural authorities governing farm registration and veterinary-drug manufacturing, carries a large amount of pending litigation on both sides of the docket, and reports currency exposure reaching into Egypt and Myanmar alongside China.